Skip To Main Content
Lilly Asia Ventures on Muck Rack

Lilly Asia Ventures

As seen in: BioSpace, Monterey County Now, BioCentury
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lilly Asia

Contact Lilly Asia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs

|
By Connect Biopharmaceuticals, Boxer Capital, Lilly Asia Ventures
| Monterey County Now Verified
- In an oversubscribed round, top-tier investors provide significant financial resources to accelerate clinical development of potentially best-in-class therapies for inflammatory/autoimmune diseases - SAN DIEGO and TAICANG, SUZHOU, China, Aug.
Open in Who Shared View Duplicates (6) Issue with article?

How Lilly Asia Ventures came to invest in U.S. companies

|
By Virginia Li Verified, Judith L. Li, Lilly Asia Ventures
| BioCentury Verified
What began as a fund designed to provide Eli Lilly and Co. access to innovation in China has evolved into an independent VC with a focus on innovative Chinese healthcare companies and U.S. biotechs looking to enter the China market. Eli Lilly was the sole LP in two initial funds of undisclosed size that closed in 2008 and 2011. In 2015 Lilly Asia Ventures added external LPs to close the firm’s third fund at $300 million.
Open in Who Shared Issue with article?

Singlera Genomics Raises 20 Million In Series A Financing Led By Lilly Asia Ventures

|
By Lilly Asia Ventures
| BioSpace Verified
LA JOLLA, Calif., Aug. 22, 2016 /PRNewswire/ -- Singlera Genomics, a fast-growing, non-invasive genetic testing company, today announced it has successfully raised US$20 million in a Series A financing. The financing round was led by Lilly Asia Ventures, together with Green Pine Capital Partners, CDBI Partners and others. Based in La Jolla and Shanghai, Singlera has proprietary technologies in single cell sequencing, DNA methylation and bioinformatics.
Open in Who Shared Issue with article?
See all 3 articles